Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Assessing biological responses to SU11248 in a Phase I clinical trial of patients with imatinib -resistant gastrointestinal stromal tumors (GIST):

Cherrington JM, Van den Abbeele A, Badawi RD, Lechpammer S, McCarthy TJ, Corless CL, ChoenDP, Scigalla P, Fletcher JA, and Demetri GD. Assessing biological responses to SU11248 in a Phase I clinical trial of patients with imatinib -resistant gastrointestinal stromal tumors (GIST):. Pharmacodynamic evaluation using 18 FDG-PET functional imaging, pharmacokinetics, and modulation of blood biomarkers. 2003.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.